Trials / Completed
CompletedNCT01773226
Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA)
A Prospective Single-Center Clinical Study of a Single Intra-Articular Injection of Autologous Protein Solution ("APS(TM)") in Patients With Osteoarthritis (OA) of the Knee
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This prospective single-center study will evaluate the safety and tolerability of a single dose of "APS(TM)" treated patients with OA of the knee who have failed conservative OA therapy. The study will also evaluate efficacy by assessing patient pain and functionality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Autologous Protein Solution "APS(TM)" | A therapy prepared at the point-of-care from a small sample of the patient's own blood containing high concentrations of anti-inflammatory and anabolic proteins |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-01-23
- Last updated
- 2018-02-05
- Results posted
- 2016-06-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01773226. Inclusion in this directory is not an endorsement.